glp 1 friendly Caution advised for GLP-1 labeling Co-op Launches Own-Brand GLP-1 Friendly

Tirzepatide was approved in 2022 as Mounjaro for diabetes, and in 2024 as Zepbound for obesity, with exclusivity running until May 2027

All-Inclusive pricing, no hidden fees

Originally developed to treat type 2 diabetes (T2D), these drugs have since delivered major advances in managing obesity and cardiovascular risk reduction

This daily oral supplement is formulated for both men and women with probiotics, berberine, and GLP-supporting botanicals

Insurance coverage for GLP-1 weight loss, Wegovy, Zepbound, Ozempic, Mounjaro, bariatric surgery, and the Medicare GLP-1 Bridge Program in Florida

Repatha is used to lower high cholesterol alongside dietary changes and to reduce the risk of major cardiovascular events in those at increased risk for these events, such as death from cardiovascular disease, heart attack, stroke, angina requiring hospitalization, or certain types of heart surgery